GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human KRAS G12A mutant in complex with gppnhp

Analyse Crystal structure of human KRAS G12A mutant in complex with gppnhp in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VPY
Type
protein
Length
312 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
9GM, MG
Pockets
4 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGTPase KRASprotein15633% helix, 26% strandP01116

Ligands and binding sites

  • 9GM · 2-amino-9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonoamino)phosphoryl]oxy}phosphoryl]-alpha-L-xylofuranosyl}-1,9-dihydro-6H-purin-6-one · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • PG4 · Tetraethylene glycol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11790.470.7630PG4
2840.360.7624empty
31000.350.7422MG, 9GM
4840.340.7524MG, 9GM

Interfaces

1 interface between chains.

  • A–B · 1064 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 5VPY · Crystal structure of human KRAS G12A mutant in complex with GppNHp · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.